Vaxart, Inc. (VXRT)
Vaxart, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Vaxart, Inc. (VXRT) is a Biotechnology company based in US with a market capitalization of $121M. Revenue grew 726.7% year-over-year and the company generated $7.6M in free cash flow. This page tracks VXRT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 105 employees · IPO Dec 11, 1981
Valuation
Valuation & price
$0.68as of May 17, 2026· -15.0% vs 52w high
9.6
P/E ratio
Latest-FY diluted EPS
1.38
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$121M
Market cap
726.7%
Revenue growth (YoY)
100.0%
Gross margin
$7.6M
Free cash flow (USD)
-$54.8M
Net debt
Net cash position
-52.7%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2017 → 2025
Free cash flow by year
2017 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 7, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJul 17, 2026Filing
Annual Meeting Results
- 8-K eventJul 7, 2026Filing
Clinical Trial Results
- 8-K eventJul 2, 2026Filing
Cooperation Agreement
- 8-K eventJun 26, 2026Filing
Funding Modification
- 8-K eventMay 19, 2026Filing
Preliminary Proxy Statement Filed
- 8-K eventMay 7, 2026Filing
Business Update and Financial Results
- Quarterly reportMay 7, 2026Filing
10-Q Filed
- Annual reportApr 30, 2026Filing
10-K Filed
- 8-K eventApr 23, 2026Filing
Director Appointment
- 8-K eventApr 21, 2026Filing
Lease Amendment
Questions
Frequently asked questions
What is Vaxart, Inc.'s market cap?
Vaxart, Inc. (VXRT) has a market capitalization of $121M.
What is VXRT's P/E ratio?
VXRT trades at a price-to-earnings ratio of 9.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is VXRT's price-to-book (P/B) ratio?
VXRT trades at 1.38 times book value per share.
Are insiders buying VXRT stock?
SEC Form 4 filings show no open-market insider buys at Vaxart, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.